NP
HRMY icon

Newlight Partners’s Harmony Biosciences HRMY Stock Holding History

Newlight Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-151
Closed -$7K – 4
2022
Q3 		$7K Hold
151
– – ﹤0.01% 5
2022
Q2 		$7K Sell
151
-651,221
-100% -$29.3M ﹤0.01% 5
2022
Q1 		$31.7M Sell
651,372
-249,452
-28% -$10.2M 2.15% 4
2021
Q4 		$38.4M Sell
900,824
-1,000,000
-53% -$39.9M 2.12% 4
2021
Q3 		$72.9M Sell
1,900,824
-765,632
-29% -$24.7M 3.16% 4
2021
Q2 		$75.3M Sell
2,666,456
-2,441
-0.1% -$73.2K 2.79% 3
2021
Q1 		$88.2M Hold
2,668,897
– – 3.13% 3
2020
Q4 		$96.5M Hold
2,668,897
– – 2.9% 3
2020
Q3 		$90.5M Buy
+2,668,897
New +$97.3M 3.01% 3

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Newlight Partners's HRMY Position: Q4 2022 in Review

Newlight Partners sold out of Harmony Biosciences (HRMY) in Q4 2022, closing a stake of 151 shares — an estimated $7K sold.

Newlight Partners first reported a position in HRMY in Q3 2020 and held it in 9 quarters. The position peaked at $96.5M in Q4 2020. 242 funds tracked by Wall St. Rank hold HRMY as of Q4 2022.

  • Newlight Partners reported no remaining Harmony Biosciences position as of Q4 2022 after selling out during the quarter.
  • Newlight Partners sold 151 Harmony Biosciences shares in Q4 2022, an estimated $7K.
  • Newlight Partners first reported a position in Harmony Biosciences in Q3 2020 and held it in 9 quarters.
  • Newlight Partners's Harmony Biosciences position peaked at $96.5M in Q4 2020.
  • 242 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2022.

Based on Newlight Partners's 13F filing for Q4 2022, filed 13 Feb 2023.